Page last updated: 2024-10-16

gamma-aminobutyric acid and Dyslipidemias

gamma-aminobutyric acid has been researched along with Dyslipidemias in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsiakitzis, KC1
Rekka, EA1
Kourounakis, AP1
Kourounakis, PN1

Other Studies

1 other study available for gamma-aminobutyric acid and Dyslipidemias

ArticleYear
Novel compounds designed as antistress agents.
    Journal of medicinal chemistry, 2009, Nov-26, Volume: 52, Issue:22

    Topics: Amides; Animals; Anti-Anxiety Agents; Antioxidants; Benzoates; Brain; Carboxylic Acids; Chromans; Dr

2009